Evidence map›Paper›PMID 32152088›Full record

ArticleAntimicrobial agents and chemotherapy2020

Encephalitozoon cuniculi Genotype III Evinces a Resistance to Albendazole Treatment in both Immunodeficient and Immunocompetent Mice.

Bohumil Sak, Klára Brdíčková, Nikola Holubová, Dana Květoňová, Lenka Hlásková, Martin Kváč

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Chemical disinfection ofFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Comparison of the Concentration ofJournal of inflammation research · 2022
    Article
  7. Review
  8. Sparse Evidence forPathogens (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Journal of inflammation research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bohumil SakInstitute of Parasitology, Biology Centre, Czech Academy of Science, České Budějovice, Czech Republic casio@paru.cas.cz.
Klára BrdíčkováFaculty of Science, University of South Bohemia in České Budějovice, České Budějovice, Czech Republic.
Nikola HolubováInstitute of Parasitology, Biology Centre, Czech Academy of Science, České Budějovice, Czech Republic.
Dana KvětoňováInstitute of Parasitology, Biology Centre, Czech Academy of Science, České Budějovice, Czech Republic.
Lenka HláskováInstitute of Parasitology, Biology Centre, Czech Academy of Science, České Budějovice, Czech Republic.
Martin KváčInstitute of Parasitology, Biology Centre, Czech Academy of Science, České Budějovice, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Of four genotypes of

Indexed as

AlbendazoleAnimalsAntifungal AgentsCD4 AntigensCD8 AntigensCell LineChlorocebus aethiopsColony Count, MicrobialDisease Models, AnimalEncephalitozoon cuniculiEncephalitozoonosisGenotypeImmunocompromised HostMiceMice, Inbred BALB CMice, Inbred C57BLAlbendazoleAntifungal AgentsCD4 AntigensCD8 AntigensalbendazoleEncephalitozoon cuniculigenotype IIImicrosporidiosistolerancetreatment

Identifiers

PMID32152088
PMCPMC7179643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.